Skip UCSF navigation|About accessibility UCSF University of California, San Francisco
About UCSF
Search UCSF
UCSF Medical Center
End of UCSF navigation
School of Pharmacy

End of section-level navigation

IMG_1890.JPG - ungjustine
IMG_1762.JPG - ungjustine
Bird's eye view - davidhanddotnet
Lange Reading Room - UCSF Library
Golden Gate Bridge - tuxmann
UCSF Mission Bay - UCSF School of Pharmacy (University of California)
Hippocrates & Ambulatory Care Center - frankfarm
Sculpture at UCSF Mission Bay - funcrunch
Mastering medicines to maximize health

What Happens Here

  • Education of PharmD and PhD students
  • Further training of postgraduates
  • Scientific discoveries
  • Answers to clinical, social, behavorial, and health policy research questions
  • Pharmaceutical care of patients
  • Service to the public.

Signs of Our Success

3 goals 5 years 1 plan

About the School

Mission, School Profile, Accomplishments, History, Funding, Leadership, Administration, Board of Advisors

Visit the School

Maps & Locations, Virtual Tour

Information for

Prospective Students, Current Students, Alumni, Faculty and Staff

Campus and UC Connections

The UCSF School of Pharmacy is one of four health sciences schools, a graduate division, and a medical center at the University of California, San Francisco, which is one of 10 campuses in the UC system.

Malawi Youmans Returns to Malawi

Follow blogger and UCSF School of Pharmacy faculty member Sharon Youmans as she returns to The Republic of Malawi to continue her HIV/AIDS research.

Blog:

Sharon Youmans' Research Journeys to Malawi

News Headlines on November 23, 2009

Craik to Lead Takeda-sponsored Research on Antibodies

Craik Takeda San Francisco, Inc., announced September 21, 2009 that that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles Craik, PhD, faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy. Craik will be the principal investigator of the project, which will focus on therapeutic antibody discovery and development to an undisclosed target. Item: Full Story:Takeda San Francisco Enters into a Sponsored Research Agreement with UCSF

Image credit: © majedphoto.com

UCSF Researchers Join Consortium to Target Cancer in New Ways

Arkin and WellsScientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer. Department Chair James Wells, PhD, with department faculty member Michelle Arkin, PhD, will lead UCSF's participation in the new National Cancer Institute initiative, called the Chemical Biology Consortium (CBC). The UCSF team will use small molecules to "search" the surface of cells for possible new "druggable" sites. At the heart of UCSF's CBC work will be the Small Molecule Discovery Center, which Wells directs. Item: Full Story: UCSF Researchers Join Consortium to Target Cancer in New Ways

Kroetz Discusses Pharmacogenomics on KQED 'Quest' Radio

KroetzUCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009. Fellow members of the interview panel were UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and UCSF breast cancer surgeon Laura Esserman, MD, MBA. Item: Full Story: Kroetz Discusses Pharmacogenomics on KQED Quest Radio.

Image credit: © majedphoto.com

Study Identifies Lack of Information about HER2 Testing Practices

PhillipsBreast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective. These conclusions appear in the first major research report from the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) established in 2008 by the UCSF School of Pharmacy, Department of Clinical Pharmacy. Center Director Kathryn Phillips, PhD, was the lead author of the paper that appeared in Cancer, online September 14, 2009. Phillips and colleagues found that little evidence is available to determine whether all eligible patients are tested, how many are retested to confirm results, and how many with negative HER2 test results still receive trastuzumab. Item: Full Story: Many Breast Cancer Patients May Not Be Receiving Recommended Test

More News: News Archive, News Feed: news feed, Update From The Dean, Press Releases, UCSF Today.

Calendars

Instructional Facilities

Other Links